Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Adalimumab-bwwd injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis. It is used in children 2 years of age and older for juvenile idiopathic arthritis. This medicine is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-bwwd may be used alone or in combination with other medicines (eg, methotrexate).
Adalimumab-bwwd injection is also used to treat moderate to severe active Crohn's disease. It is also used to treat moderate to severe ulcerative colitis.
Adalimumab-bwwd injection is also used to treat moderate to severe chronic plaque psoriasis, which is a skin disease with red patches and white scales that do not go away. It is given to patients who may receive other types of treatment, including pills, injection, or phototherapy (light treatment).
This medicine is available only with your doctor's prescription.
Portions of this document last updated: May 01, 2023
Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.